Isocitrate Dehydrogenase Mutation Assessment in Human Glioma Using Desorption Electrospray Ionization–Multiple Reaction Monitoring
Analytical Chemistry · 04.08.2026 · 98 (30) · 22080-22087
DOI: 10.1021/acs.analchem.6c00520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 21.07.2026. Verfasst von Mahdiyeh Shahi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma, Spectrometry, Mass, Electrospray Ionization, Mutation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Mayo Clinic, NINDS NIH HHS.
Abstract (Originalsprache)
The mutation status of isocitrate dehydrogenase (IDH) in glioma patients has diagnostic and prognostic significance but is available only after surgery. Rapid and sensitive intraoperative molecular diagnosis is essential for distinguishing tumor from infiltrative and from normal brain tissue to maximize safe resection. IDH-mutant (mut)tumors produce high concentrations of 2-hydroxyglutarate (2HG), which serves as a surrogate marker of IDH mutation. Here, we use desorption electrospray ionization-multiple reaction monitoring (DESI-MRM), a form of mass spectrometry (MS), for rapid prediction of IDH mutation status. A set of 30 human brain smears was analyzed using DESI-MRM experiments to predict the mutation status of IDH and quantify 2HG in glioma samples within 2 min (endogenous reference molecule) or 7 min (external standard). Nanoelectrospray ionization (nESI) was employed as a validation method. An isotopically labeled surrogate internal standard allowed quantitative measurement of 2HG and clear separation between IDH-mut and IDH-wildtype (wt) samples, showing 100% agreement with clinical diagnosis. 2HG concentrations in IDH-mut samples ranged from 88 to 1445 ng mg–1, while IDH-wt samples exhibited 2HG concentrations of 9–15 ng mg–1. Calibration curves showed method accuracy within ≤15%. The quantitative results obtained using isotopically labeled standards showed a strong correlation between IDH mutation score and 2HG concentrations, as did an earlier semiquantitative (ratiometric, endogenous standard) method. These findings highlight the standalone capability of DESI-MRM for making measurements to justify assessments for intraoperative diagnosis and to support surgical decision-making to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States.
- Department of Neurosurgery, Washington University in St. Louis, St. Louis, Missouri63110, United States.
- Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida32224, United States.
ORCID-Profile: R Graham Cooks
Förderung
- NCI NIH HHS
- Mayo Clinic
- NINDS NIH HHS
- Florida Department of Health
- NCATS NIH HHS
- Waters Scientific Corporation
- National Center for Advancing Translational Sciences
- National Cancer Institute
Zitieren
APA
Shahi, M., Garcia, D. M., Quiñones-Hinojosa, A., & Cooks, R. G. (2026). Isocitrate Dehydrogenase Mutation Assessment in Human Glioma Using Desorption Electrospray Ionization–Multiple Reaction Monitoring. Analytical Chemistry, 98(30), 22080-22087. https://doi.org/10.1021/acs.analchem.6c00520
Vancouver
Shahi M, Garcia DM, Quiñones-Hinojosa A, Cooks RG. Isocitrate Dehydrogenase Mutation Assessment in Human Glioma Using Desorption Electrospray Ionization–Multiple Reaction Monitoring. Analytical Chemistry. 2026;98(30):22080-22087. doi:10.1021/acs.analchem.6c00520
BibTeX
@article{Shahi2026,
author = {Shahi, Mahdiyeh and Garcia, Diogo Moniz and Quiñones-Hinojosa, Alfredo and Cooks, R Graham},
title = {Isocitrate Dehydrogenase Mutation Assessment in Human Glioma Using Desorption Electrospray Ionization–Multiple Reaction Monitoring},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {30},
pages = {22080--22087},
doi = {10.1021/acs.analchem.6c00520}
}
EUVIMED